Skip to content
Screener

Enovis ENOV Net Change in Cash

Net Change in Cash at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
Stryker logo
StrykerSYK
$513M
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$35.76M+241%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$14.2M
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
$3.07M+158%
ESAB logo
ESABESAB
$818.93M+1,850%

Other financials

Income statement

See full
Revenue$582.8M+3.2%
Gross profit$359.2M+7.3%
Operating income$17.4M+204%
Net income-$1.2M+96.8%
EPS (diluted)-$0.02+96.9%

Balance sheet

See full
Cash & equivalents$12.6M-71.5%
Total debt$1.3B-6.4%
Total equity$1.5B-42.7%
Total assets$3.8B-25.0%

Cash flow

See full
Operating cash flow$75.0M+57.1%
CapEx$43.9M-1.1%
Free cash flow$31.1M

Valuation

See full
Market cap$1.53B-5.5%
Enterprise value$2.83B-4.9%
P/S0.7×-0.1×

Profitability

See full
Gross margin61.1%+3.5pp
Operating margin-45.1%+19.4pp
Net margin-48%+17.7pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-54.3%+672pp
Debt / equity0.9×+0.3×
Current ratio-0.3×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: Enovis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001420800-26-000035
Line itemSix Months Ended / July 3, 2026Six Months Ended / July 4, 2025
Payments of tax withholding for stock-based awards(1,473)(3,447)
Proceeds from issuance of common stock, net1,0081,129
Deferred consideration payments and other(9,068)(2,265)
Net cash provided by (used in) financing activities(24,542)57,422
Effect of foreign exchange rates on Cash and cash equivalents(161)2,632
Decrease in Cash and cash equivalents(23,826)(4,093)
Cash and cash equivalents, beginning of period36,38948,167
Cash and cash equivalents, end of period$12,563$44,074

Item 1. Financial Statements

FAQ

What is Enovis's net change in cash?
Enovis (ENOV) reported net change in cash of -$20.57M in Q2 2026.
What is the long-term trend for Enovis's net change in cash?
Over 3 years (2021 to 2024), Enovis's net change in cash has grown at a -82.5% compound annual growth rate (CAGR), from $618.3M to $3.34M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about Enovis's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude